SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-456521"
 

Search: onr:"swepub:oai:DiVA.org:uu-456521" > Lowering cholestero...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Bosch, JackieHamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.;McMaster Univ, Sch Rehabil Sci, IAHS, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada. (author)

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events : results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-05-08
  • Oxford University Press,2021
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-456521
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456521URI
  • https://doi.org/10.1093/eurheartj/ehab225DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) events by 24% in 12 705 participants at intermediate CV risk after 5.6 years. There was no benefit of blood pressure (BP) lowering treatment in the overall group, but a reduction in events in the third of participants with elevated systolic BP. After cessation of all the trial medications, we examined whether the benefits observed during the active treatment phase were sustained, enhanced, or attenuated.Methods and results: After the randomized treatment period (5.6 years), participants were invited to participate in 3.1 further years of observation (total 8.7 years). The first co-primary outcome for the entire length of follow-up was the composite of myocardial infarction, stroke, or CV death [major adverse cardiovascular event (MACE)-1], and the second was MACE-1 plus resuscitated cardiac arrest, heart failure, or coronary revascularization (MACE-2). In total, 9326 (78%) of 11 994 surviving Heart Outcomes Prevention Evaluation (HOPE)-3 subjects consented to participate in extended follow-up. During 3.1 years of post-trial observation (total follow-up of 8.7 years), participants originally randomized to rosuvastatin compared with placebo had a 20% additional reduction in MACE-1 [95% confidence interval (CI), 0.64-0.99] and a 17% additional reduction in MACE-2 (95% CI 0.68-1.01). Therefore, over the 8.7 years of follow-up, there was a 21% reduction in MACE-1 (95% CI 0.69-0.90, P = 0.005) and 21% reduction in MACE-2 (95% CI 0.69-0.89, P = 0.002). There was no benefit of BP lowering in the overall study either during the active or post-trial observation period, however, a 24% reduction in MACE-1 was observed over 8.Conclusion: The CV benefits of rosuvastatin, and BP lowering in those with elevated systolic BP, compared with placebo continue to accrue for at least 3 years after cessation of randomized treatment in individuals without cardiovascular disease indicating a legacy effect. [GRAPHICS] .

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Lonn, Eva M.Hamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.;McMaster Univ, Dept Med, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada. (author)
  • Jung, HyejungHamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada. (author)
  • Zhu, JunChinese Acad Med Sci & Peking Union Med Coll, Fu Wai Hosp, 9 Dongdan 3rd Alley, Beijing, Peoples R China. (author)
  • Liu, LishengChinese Acad Med Sci & Peking Union Med Coll, Fu Wai Hosp, 9 Dongdan 3rd Alley, Beijing, Peoples R China. (author)
  • Lopez-Jaramillo, PatricioUniv Santander, Fac Salud, Inst Masira, Calle 70 55-210, Bucaramanga, Colombia. (author)
  • Pais, PremSt Johns Res Inst, 100 Feet Rd, Bangalore 560034, Karnataka, India. (author)
  • Xavier, DenisSt Johns Res Inst, 100 Feet Rd, Bangalore 560034, Karnataka, India.;St Johns Med Coll, Sarjarpur Rd, Bangalore 560034, Karnataka, India. (author)
  • Diaz, RafaelInst Cardiovasc Rosario, DSR, Bv Orono 440,S2000, RA-440 Rosario, Santa Fe, Argentina. (author)
  • Dagenais, GillesUniv Laval, Inst Univ Cardiol & Pneumol Quebec, 2725 Ch Ste Foy, Ste Foy, PQ G1V 4G5, Canada. (author)
  • Dans, AntonioUniv Philippines, Coll Med, Pedro Gil St,Taft Ave, Manila 1000, Metro Manila, Philippines. (author)
  • Avezum, AlvaroDante Pazzanese Inst Cardiol, Av Dr Dante Pazzanese 500, BR-04012909 Sao Paulo, SP, Brazil.;Univ Sao Paulo, Av Dr Dante Pazzanese 500, BR-04012909 Sao Paulo, SP, Brazil. (author)
  • Piegas, Leopoldo S.HCor Hosp Coracao, Eliseu Guilherme 147, BR-04004030 Sao Paulo, SP, Brazil. (author)
  • Parkhomenko, AlexanderInst Cardiol, Narodnoho Opolchennya St 5, UA-03680 Kiev, Ukraine. (author)
  • Keltai, KatiSemmelweis Univ, Hungarian Inst Cardiol, Budapest, Hungary. (author)
  • Keltai, MatyasSemmelweis Univ, Hungarian Inst Cardiol, Budapest, Hungary. (author)
  • Sliwa, KarenUniv Cape Town, Hatter Inst Cardiovasc Res, Dept Med, Soweto Cardiovasc Res Grp, 4th 5th & 6th Floor, Cape Town, South Africa. (author)
  • Held, Claes,1956-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)clahe947 (author)
  • Peters, Ronald J. G.Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands. (author)
  • Lewis, Basil S.Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Ruth & Bruce Rappaport Sch Med, Efron St 1, Haifa, Israel. (author)
  • Jansky, PetrUniv Hosp Motol, V Uvalu 84, Prague 15006 5, Czech Republic. (author)
  • Yusoff, KhalidUniv Teknol Majlis Amansh Rakyat, Jalan Ilmu 1-1, Shah Alam 40450, Selangor, Malaysia.;Univ Coll Sedaya Int Univ, UCSI Hts,1 Jalan Puncak Menara Gading, Kuala Lumpur 56000, Malaysia. (author)
  • Khunti, KamleshLeicester Diabet Ctr, Gwendolen Rd, Leicester LE5 4PW, Leics, England. (author)
  • Toff, William D.Univ Leicester, Dept Cardiovasc Sci, Univ Rd, Leicester LE1 7RH, Leics, England.;Glenfield Hosp, Leicester Biomed Res Ctr, UK & Natl Inst Hlth Res, Groby Rd, Leicester LE3 9QP, Leics, England. (author)
  • Reid, Christopher M.Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 553, Australia.;Curtin Univ, Sch Publ Hlth, Kent St, Bentley Perth, WA 6102, Australia. (author)
  • Varigos, JohnMonash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 553, Australia. (author)
  • Joseph, PhilipHamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.;McMaster Univ, Sch Rehabil Sci, IAHS, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada. (author)
  • Leiter, Lawrence A.Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, 209 St, Toronto, ON M5B 1T8, Canada.;Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, 209 Victoria St, Toronto, ON M5B 1T8, Canada.;Univ Toronto, Keenan Res Ctr Biomed Sci, St Michaels Hosp, 209 Victoria St, Toronto, ON M5B 1T8, Canada. (author)
  • Yusuf, SalimHamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.;McMaster Univ, Sch Rehabil Sci, IAHS, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada. (author)
  • Hamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.;McMaster Univ, Sch Rehabil Sci, IAHS, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada.Hamilton Hlth Sci, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.;McMaster Univ, Dept Med, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada. (creator_code:org_t)

Related titles

  • In:European Heart Journal: Oxford University Press42:31, s. 2995-30070195-668X1522-9645

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view